| 注册
首页|期刊导航|中国临床药理学杂志|左卡尼汀联合辅酶 Q10治疗重症慢性心力衰竭的临床疗效及安全性评价

左卡尼汀联合辅酶 Q10治疗重症慢性心力衰竭的临床疗效及安全性评价

丁勇 杨秀玲

中国临床药理学杂志Issue(20):1993-1995,3.
中国临床药理学杂志Issue(20):1993-1995,3.DOI:10.13699/j.cnki.1001-6821.2015.20.003

左卡尼汀联合辅酶 Q10治疗重症慢性心力衰竭的临床疗效及安全性评价

Clinical efficacy and safety of L -carnitine and coenzyme Q10 in treatment of severe chronic heart failure

丁勇 1杨秀玲2

作者信息

  • 1. 河南大学医学院,河南开封 475000
  • 2. 开封市第一人民医院 心血管内科,河南 开封 475000
  • 折叠

摘要

Abstract

Objective To evaluate the clinical effect and safety of L-carnitine and coenzyme Q10 on the treatment of chronic heart failure. Methods One hundred ninety-six patients with chronic heart failure cardiacⅢ-Ⅳlevel were paired by age and gender, and each pair were randomly divided into experimental group and the control group, every group has 98 patients.The control group was treated with metoprolol 100 mg, bid +chlorine 50 mg qd +spironolactone 40 mg bid conventional heart failure treatment.The experimental group was added with L-carni-tine (20 mg・ kg -1 ,bid) and coenzyme Q10 (10 mg tid) on the basis of conventional treatment. After treatment, the improvement of cardiac function and incidence of adverse drug reactions between the two groups were compared. Results The total effective rate of treatment group (89.80%) is significantly higher than that in control group 63.27%(P<0.05).After treatment, the C reactive protein content and the brain natriuretic peptide ( BNP) level of experimental group were signifi-cantly lower than those in control group ( P<0.05).6 min walking dis-tance of patients in experimental group is longer than that in control group.The left ventricular ejection fraction ( LVEF) of treatment group&nbsp;was significantly higher than that in control group and the left ventricular diastolic diameter ( LVEDD) and left ventricular end systolic diameter ( LVESD) significantly lower than those of control group.The adverse reactions between the two groups have no significant difference (P>0.05).Conclusion L-carnitine combined coenzyme Q10 can significantly improve the treatment effect of severe chronic heart failure without increasing of the incidence of adverse drug reactions.

关键词

左卡尼汀/辅酶Q10/慢性心力衰竭/心功能

Key words

L-carnitine/coenzyme Q10/chronic heart failure/cardiac function

分类

医药卫生

引用本文复制引用

丁勇,杨秀玲..左卡尼汀联合辅酶 Q10治疗重症慢性心力衰竭的临床疗效及安全性评价[J].中国临床药理学杂志,2015,(20):1993-1995,3.

基金项目

2012年度河南省科技攻关重点项目基金资助项目 ()

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文